WHO ICTRP trial
Multi-omics and biometrical integrated characteristics predict PD-1 clinical…
ChiCTR2000036804 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000036804 |
|---|---|
| Public title | Multi-omics and biometrical integrated characteristics predict PD-1 clinical outcomes in stage (III-IV) melanoma -- a precise clinical study |
| Scientific title | Analysis of PD-1 inhibitors in the treatment of melanoma, utilizing multi-omics and biometrical integrated characteristics |
| Primary sponsor | Zhongshan Hospital, Fudan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | China |
| Conditions | Melanoma |
| Interventions | Case series:null |
| Registration date | Aug 25, 2020 |
| Target size | Case series:118 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: